Skip to main content
SpringerLink
Log in

Metformin use in pregnancy: efficacy, safety, and potential benefits

  • Opinion
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358(19):1991–2002. https://doi.org/10.1056/NEJMoa0707943. (PMID: 18463375)

    Article  Google Scholar 

  2. Standard Italiani per la cura del diabete mellito. SID-AMD, (2018) https://www.siditalia.it/clinica/standard-di-cura-amd-sid

  3. American Diabetes Association (2020) Standards of medical care in diabetes—2020 abridged for primary care providers. Clin Diabetes 38(1):10–38. https://doi.org/10.2337/cd20-as01

    Article  PubMed Central  Google Scholar 

  4. American Diabetes Association Professional Practice Committee (2022) 15 Management of diabetes in pregnancy: standards of medical care in diabetes—2022. Diabetes Care 45(Suppl. 1):S232–S243

    Article  Google Scholar 

  5. IDF Clinical Guidelines Task Force. (2009) Global Guideline on pregnancy and diabetes. Brussels: International Diabetes Federation, Available at: https://www.idf.org/e-library/guidelines/84-pregnancy-and-diabetes.html

  6. Glucophage® for use during pregnancy, Merck. Retrieved Oct 17, 2022, from https://www.merckgroup.com/en/news/glucophage-oral-diabetes-treatment-28-02-2022.html

  7. AIFA. Modifica dell'autorizzazione all'immissione in commercio del medicinale per uso umano, a base di metformina cloroidrato, “Glucophage Unidie”. GU Serie Generale n° 95 del 23–04–2022

  8. Lee HY, Wei D, Loeken MR (2014) Lack of metformin effect on mouse embryo AMPK activity: implications for metformin treatment during pregnancy. Diabetes Metab Res Rev 30:23–30. https://doi.org/10.1002/dmrr.2451pmid:23983188

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Denno KM, Sadler TW (1992) Oral hypoglycemic agents: biguanides and their effects on developing mouse embryos. Teratology 45:477–478

    Google Scholar 

  10. Denno KM, Sadler TW (1994) Effects of the biguanide class of oral hypoglycemic agents on mouse embryogenesis. Teratology 49:260–266. https://doi.org/10.1002/tera.1420490405pmid:8073364

    Article  CAS  PubMed  Google Scholar 

  11. Cassina M, Donà M, Di Gianantonio E, Litta P, Clementi M (2014) First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis. Hum Reprod Update 20:656–669. https://doi.org/10.1093/humupd/dmu022pmid:24861556

    Article  CAS  PubMed  Google Scholar 

  12. Gilbert C, Valois M, Koren G (2006) Pregnancy outcome after first-trimester exposure to metformin: a meta-analysis. Fertil Steril 86:658–663. https://doi.org/10.1016/j.fertnstert.2006.02.098pmid:16879826

    Article  CAS  PubMed  Google Scholar 

  13. Panchaud A, Rousson V, Vial T et al (2018) Pregnancy outcomes in women on metformin for diabetes or other indications among those seeking teratology information services. Br J Clin Pharmacol 84:568–578. https://doi.org/10.1111/bcp.13481pmid:29215149

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Given JE, Loane M, Garne E, Addor MC, Bakker M, Bertaut-Nativel B, Gatt M, Klungsoyr K, Lelong N, Morgan M, Neville AJ, Pierini A, Rissmann A, Dolk H (2018) Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control study. BMJ 25(361):k2477. https://doi.org/10.1136/bmj.k2477

    Article  Google Scholar 

  15. Rowan JA, Hague WM, Gao W, Battin MR, More MP, MiG Trial Investigators (2008) Metformin vs insulin for the treatment of gestational diabetes. N Engl J Med 358:2004–2015

    Article  Google Scholar 

  16. Feig DS, Donovan LE, Zinman B, Sanchez JJ, Asztalos E, Ryan EA, Fantus IG, Hutton E, Armson AB, Lipscombe LL, Simmons D, Barrett JFR, Karanicolas PJ, Tobin S, McIntyre HD, Tian SY, Tomlinson G, Murphy KE, MiTy Collaborative Group (2020) Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol 8(10):834–844. https://doi.org/10.1016/S2213-8587(20)30310-7. (Erratum in: Lancet Diabetes Endocrinol. 2020 Nov;8(11):e6. PMID: 32946820)

    Article  CAS  PubMed  Google Scholar 

  17. Picón-César MJ, Molina-Vega M, Suárez-Arana M, González-Mesa E, Sola-Moyano AP, Roldan-López R, Romero-Narbona F, Olveira G, Tinahones FJ, González-Romero S (2021) Metformin for gestational diabetes study: metformin vs insulin in gestational diabetes: glycemic control and obstetrical and perinatal outcomes: randomized prospective trial. Am J Obstet Gynecol 225(5):517.e1-517.e17. https://doi.org/10.1016/j.ajog.2021.04.229. (Epub 2021 Apr 19 PMID: 33887240)

    Article  CAS  PubMed  Google Scholar 

  18. He K, Guo Q, Ge J, Li J, Li C, Jing Z (2022) The efficacy and safety of metformin alone or as an add-on therapy to insulin in pregnancy with GDM or T2DM: a systematic review and meta-analysis of 21 randomized controlled trials. J Clin Pharm Ther 47(2):168–177

    Article  CAS  PubMed  Google Scholar 

  19. Tarry-Adkins JL, Ozanne SE, Aiken CE (2021) Impact of metformin treatment during pregnancy on maternal outcomes: a systematic review/meta-analysis. Sci Rep 11(1):9240. https://doi.org/10.1038/s41598-021-88650-5. (PMID: 33927270)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Tarry-Adkins JL, Aiken CE, Ozanne SE (2020) Comparative impact of pharmacological treatments for gestational diabetes on neonatal anthropometry independent of maternal glycaemic control: a systematic review and meta-analysis. PLoS Med 17(5):e1003126. https://doi.org/10.1371/journal.pmed.1003126.PMID:32442232;PMCID:PMC7244100

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Mirabelli M, Chiefari E, Tocci V, Greco E, Foti D, Brunetti A (2021) Gestational diabetes: Implications for fetal growth, intervention timing, and treatment options. Curr Opin Pharmacol 60:1–10. https://doi.org/10.1016/j.coph.2021.06.003. (Epub 2021 Jul 14 PMID: 34280703)

    Article  CAS  PubMed  Google Scholar 

  22. Rowan JA, Rush EC, Plank LD, Lu J, Obolonkin V, Coat S, Hague WM (2018) Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7–9 years of age. BMJ Open Diabetes Res Care 6(1):e000456

    Article  PubMed  PubMed Central  Google Scholar 

  23. Tarry-Adkins JL, Aiken CE, Ozanne SE (2019) Neonatal, infant, and childhood growth following metformin vs insulin treatment for gestational diabetes: a systematic review and meta-analysis. PLoS Med 16(8):e1002848

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Author notes

  1. G. P. Sorice and M. Caporusso have contributed equally to this work.

Authors and Affiliations

  1. Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, Department of Precision and Regenerative Medicine and Ionian Area, University of Bari Aldo Moro, 70124, Bari, Italy

    G. P. Sorice, M. Caporusso, A. Cignarelli, S. Perrini, A. Natalicchio & F. Giorgino

Authors
  1. G. P. Sorice
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Caporusso
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Cignarelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Perrini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Natalicchio
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F. Giorgino
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. Giorgino.

Ethics declarations

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Ethical approval

This article does not contain any studies directly involving human participants, as it is an opinion review of data already published.

Informed consent

For this type of study, formal consent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sorice, G.P., Caporusso, M., Cignarelli, A. et al. Metformin use in pregnancy: efficacy, safety, and potential benefits. J Endocrinol Invest 46, 633–637 (2023). https://doi.org/10.1007/s40618-022-01991-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-022-01991-4

Keywords

Search

Navigation